10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
28.31
+0.32 (1.13%)
At close: May 29, 2026, 4:00 PM EDT
27.76
-0.54 (-1.93%)
After-hours: May 29, 2026, 7:34 PM EDT
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Single Cell Instruments Revenue | 21.98M | 22.67M | 35.21M | | | | | | | |
Single Cell Instruments Revenue Growth | -3.04% | -35.62% | -26.44% | | | | | | | |
Spatial Instruments Revenue | 31.25M | 34.11M | 57.50M | | | | | | | |
Spatial Instruments Revenue Growth | -8.39% | -40.69% | -23.94% | | | | | | | |
Total Instruments Revenue | 53.23M | 56.78M | 92.72M | | | | | | | |
Total Instruments Revenue Growth | -6.26% | -38.76% | -24.91% | | | | | | | |
Single Cell Consumables Revenue | 367.99M | 363.21M | 372.31M | | | | | | | |
Single Cell Consumables Revenue Growth | 1.32% | -2.44% | -11.42% | | | | | | | |
Spatial Consumables Revenue | 153.64M | 143.98M | 121.12M | | | | | | | |
Spatial Consumables Revenue Growth | 6.71% | 18.87% | 104.47% | | | | | | | |
Total Consumables Revenue | 521.63M | 507.18M | 493.43M | | | | | | | |
Total Consumables Revenue Growth | 2.85% | 2.79% | 2.89% | | | | | | | |
| 33.91M | 32.73M | 24.32M | | | | | | | |
| 3.61% | 34.58% | 54.86% | | | | | | | |
License and Royalty Revenue | 30.02M | 46.14M | 321.00K | | | | | | | |
License and Royalty Revenue Growth | -34.93% | 14272.27% | - | | | | | | | |
| 638.78M | 642.82M | 610.79M | | | | | | | |
| -0.63% | 5.24% | -1.28% | | | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 336.39M | 346.51M | 334.32M | | | | | | | |
United States Revenue Growth | -2.92% | 3.65% | -7.16% | | | | | | | |
North America (ex-United States) Revenue | 11.92M | 12.26M | 13.45M | | | | | | | |
North America (ex-United States) Revenue Growth | -2.82% | -8.82% | 2.64% | | | | | | | |
Europe, Middle East and Africa Revenue | 166.67M | 161.72M | 159.76M | | | | | | | |
Europe, Middle East and Africa Revenue Growth | 3.06% | 1.22% | 12.29% | | | | | | | |
| 69.22M | 70.26M | 57.30M | | | | | | | |
| -1.49% | 22.63% | 12.43% | | | | | | | |
Asia-Pacific (ex-China) Revenue | 54.59M | 52.07M | 45.96M | | | | | | | |
Asia-Pacific (ex-China) Revenue Growth | 4.84% | 13.30% | -12.12% | | | | | | | |
| 638.78M | 642.82M | 610.79M | | | | | | | |
| -0.63% | 5.24% | -1.28% | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Cumulative Instruments Sold | 8.05K | 7.04K | | | | | | | |
Cumulative Instruments Sold Growth | 14.31% | 17.98% | | | | | | | |
Total Consumables Reactions Sold | 424.00K | 357.10K | | | | | | | |
Total Consumables Reactions Sold Growth | 18.73% | 2.91% | | | | | | | |
Updated May 7, 2026. Data Source:
Fiscal.ai.
